Plus Therapeutics to Present ReSPECT™-GBM Clinical Trial Data at the 2021 SNO Annual Meeting

NEXT STORY
Teladoc Health Ranks First in Consumer Satisfaction by J.D. Power 2021 Telehealth Study
PREV STORY
LexaGene Reports on Recent Veterinary Trade Shows
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Generex Biotechnology Subsidiaries NuGenerex Immuno-Oncology and NuGenerex Diagnostics Working to Address the Coronavirus Pandemic and Emerging Risk of Avian Flu Using Ii-Key Peptide Vaccines

author_avatar
NASDAQ Market News

TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas

author_avatar
NASDAQ Market News

CityMD Earns National Recognition for Connected Care

NCQA Patient-Centered Connected Care™ Recognizing Trusted Partners for Patient CareWASHINGTON, DC, May 07, 2018 ...

author_avatar
NASDAQ Market News